Research Stories

Heroin nearly killed me but pain med saved me: Max

A groundbreaking study conducted on Vancouver's Downtown Eastside has found hydromorphine could be beneficial to drug addicts trying to turn their lives around.

Results of world’s first study on new treatment for heroin addiction

The results of the ground-breaking SALOME research, published in the Journal of the American Medical Association (JAMA) Psychiatry, show chronic heroin addiction now has another effective treatment tool — hyrdomorphone, a licensed pain medication.

Treating addiction with hydromorphone saves lives and money, experts say

A longtime heroin addict named Max winds a band of blue rubber around his bicep.

Opioid Painkiller May Be New Treatment for Heroin Addicts

Hydromorphone — an opioid painkiller — may be another treatment option for heroin addiction, a new Canadian study suggests.

Injectable Hydromorphone May Be An Alternative Treatment For Chronic Heroin Addiction interviewed Dr. Eugenia Oviedo-Joekes about the results of SALOME.

Dr. Scott MacDonald interviewed about the results of SALOME

Dr. Scott MacDonald was interviewed on Roundhouse Radio 98.3 about the impact of the results of SALOME.

Groundbreaking SALOME study offers hope to heroin addicts

Global News reported on the results of SALOME.

Vancouver research spots Alzheimer’s early (St.Paul's Hospital)

With a bigger share of Canadians than ever aging into their golden years, questions about how to diagnose and treat dementia are becoming more pressing.

St. Paul’s develops a more reliable Alzheimer’s test

Mario Gregorio will sometimes go to heat a cup of water for tea only to find there’s a cup already in the microwave.

Human trials to be conducted on new Alzheimer’s test (St. Paul's Hospital)

Doctors at Vancouver’s St. Paul’s Hospital are working on a better way to figure out if a person has dementia, and what type it is. Linda Aylesworth reports.

B.C. government allocates $50 million for health research

The MSFHR has developed advances in breast cancer, human papillomavirus, and researches ways to prevent falls. The foundation is currently funnelling money into the Men’s Health Research Program which helps men deal with depression and suicide.

New drug trial to improve stroke care (PHCRI)

BC Emergency Health Services is participating in a drug trial to determine if NA-1, a neuroprotectant designed to contain the damage to the brain in the event of a stroke, is effective in reducing disability in patients with acute cerebral ischemia if administered early after symptom onset. Paramedics in Vancouver and Richmond, BC, and Toronto and Peel, ON, will be administering the clinical study drug.

Suboxone added to Pharmacare (BC Centre for Excellence in HIV/AIDS)

In an effort to address what it calls a “prescription opioid epidemic” in the province, the Ministry of Health has added Suboxone to PharmaCare coverage.

Canadian Researchers Receive Over $750,000 to Further HIV and AIDS Discover

Today the Canadian Foundation for AIDS Research (CANFAR) announced their grant allocations for HIV and AIDS research that will help us better understand the virus and work to ultimately end AIDS. As the largest charitable funder of HIV research in Canada, CANFAR is providing $765,000 to fund innovative Canadian studies that are impacting the lives of Canadians and millions of people globally. The past 30 years have seen incredible research advancements, and now is the time for Canadians to support and push forward in hopes of creating an AIDS-free future.

HIV rates in vulnerable men to be studied with $6.5M grant (Dr. Robert Hogg, BC Centre for Excellence in HIV/AIDS)

A SFU researcher is receiving a $6.5 million grant for his study on HIV rates among men who have sex with men. 

SFU researcher awarded grant to study HIV among vulnerable populations (Dr. Robert Hogg)

SFU health sciences researcher Robert Hogg has been awarded a $6.5-million grant to identify ongoing health inequities among vulnerable HIV-positive populations in B.C. and the rest of Canada.